tirzepatide type 1 diabetes trial Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with 2 (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 Groundbreaking Trial Testing Tirzepatide for

However, combining medications should still follow medical advice, especially if you have underlying health conditions or take other prescription drugs

The cardiovascular benefits of tirzepatide, including blood pressure reductions and improved lipid profiles, are particularly valuable in diabetic populations with elevated cardiovascular risk

This led to further research into the possible application of semaglutide for weight control

Prez, V

This approach helps more patients stay on the treatment, experience the full health benefits of these medications, and make real progress in reducing obesity and overweight rates in the United States."